Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Wuzhou Pharmaceutical is a comprehensive pharmaceutical enterprise based in Quzhou, China, specializing in the research, development, and large-scale production of chemical APIs and finished drug products. The company's portfolio spans several critical therapeutic areas, including endocrinology, cardiovascular health, and respiratory medicine, with a strong emphasis on high-quality generic medications. Key products include metformin and gliclazide for diabetes management, as well as various anti-infective and respiratory treatments. Operating under strict GMP standards, Wuzhou Pharmaceutical serves both the domestic Chinese market and international clients through its integrated manufacturing capabilities. The company is also involved in the production of Traditional Chinese Medicine (TCM) and health supplements, leveraging its regional expertise in Zhejiang province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Wuzhou Pharmaceutical.